Replies to post #241773 on Biotech Values

[jbog]

I've been a long time holder of Ligand mainly because I have high hopes for a radiographic drug their working on.

I don't see a need for this transaction, but the management is super conservative from my point of view. It trades wildly because there's only about 16 mil shares outstanding.

[DewDiligence]

OABI—(LGND spinoff)—begins trading tomorrow, pursuant to previously announced SPAC merger:

https://www.businesswire.com/news/home/20221101005642/en